RT Journal Article
SR Electronic
T1 Supporting COVID-19 policy response with large-scale mobility-based modeling
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.20.21254022
DO 10.1101/2021.03.20.21254022
A1 Chang, Serina
A1 Wilson, Mandy L.
A1 Lewis, Bryan
A1 Mehrab, Zakaria
A1 Dudakiya, Komal K.
A1 Pierson, Emma
A1 Koh, Pang Wei
A1 Gerardin, Jaline
A1 Redbird, Beth
A1 Grusky, David
A1 Marathe, Madhav
A1 Leskovec, Jure
YR 2021
UL http://medrxiv.org/content/early/2021/03/26/2021.03.20.21254022.abstract
AB Social distancing measures, such as restricting occupancy at venues, have been a primary intervention for controlling the spread of COVID-19. However, these mobility restrictions place a significant economic burden on individuals and businesses. To balance these competing demands, policymakers need analytical tools to assess the costs and benefits of different mobility reduction measures.In this paper, we present our work motivated by our interactions with the Virginia Department of Health on a decision-support tool that utilizes large-scale data and epidemiological modeling to quantify the impact of changes in mobility on infection rates. Our model captures the spread of COVID-19 by using a fine-grained, dynamic mobility network that encodes the hourly movements of people from neighborhoods to individual places, with over 3 billion hourly edges. By perturbing the mobility network, we can simulate a wide variety of reopening plans and forecast their impact in terms of new infections and the loss in visits per sector. To deploy this model in practice, we built a robust computational infrastructure to support running millions of model realizations, and we worked with policymakers to develop an intuitive dashboard interface that communicates our model’s predictions for thousands of potential policies, tailored to their jurisdiction. The resulting decision-support environment provides policymakers with much-needed analytical machinery to assess the tradeoffs between future infections and mobility restrictions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by NSF BIG DATA Grant IIS-1633028, NSF Grant No. OAC-1916805, NSF Expeditions in Computing Grant CCF-1918656, CCF-1917819, NSF RAPID CNS-2028004, NSF RAPID OAC-2027541, NSF OAC-1835598 (CINES), NSF OAC-1934578 (HDR), NSF CCF-1918940 (Expeditions), NSF IIS-2030477 (RAPID), Stanford Data Science Initiative, Wu Tsai Neurosciences Institute, Chan Zuckerberg Biohub, United Health Group, US Centers for Disease Control and Prevention 75D30119C05935, University of Virginia Strategic Investment Fund award number SIF160, and Defense Threat Reduction Agency (DTRA) under Contract No. HDTRA1-19-D-0007. S.C. was supported by an NSF Graduate Fellowship. P.W.K. was supported by the Facebook Fellowship Program. J.L. is a Chan Zuckerberg Biohub investigator.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:SafeGraph aggregates data from mobile applications that obtain opt-in consent from their users to collect anonymous location data. We obtained IRB exemption for SafeGraph data from the Northwestern University and University of Virginia IRB offices.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMobile phone mobility data are freely available to researchers, non-profit organizations and governments through the SafeGraph COVID-19 Data Consortium. All other data come from publicly available sources; we provide links to these data below. The dataset from The New York Times consists of aggregated COVID-19-confirmed case and death counts collected by journalists from public news conferences and public data releases. We also use data from the National Center for Health Statistics (NCHS) to estimate national excess deaths. Our state-level mask-wearing data comes from the Institute for Health Metrics and Evaluation's (IHME) public dashboard. Additional data about US census block groups come from the US American Census Survey. Our code is also available online at https://github.com/snap-stanford/covid-mobility-tool. https://www.safegraph.com/covid-19-data-consortium https://github.com/nytimes/covid-19-data https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm https://covid19.healthdata.org/united-states-of-america https://www.census.gov/programs-surveys/acs